Newfeed

BEIJING, June 26, 2024 /PRNewswire/ — CASI Pharmaceuticals, Inc. (Nasdaq: CASI) (“CASI” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products, announced today that the C

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: